Medical Devices Having Nanostructured Regions For Controlled Tissue Biocompatibility And Drug Delivery

• US 20110014264A1
• Filed: 09/23/2010
• Published: 01/20/2011
• Est. Priority Date: 12/09/2004
• Status: Abandoned Application

• Current Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Inventors: Helmus, Michael N., Ranade, Shrirang V., Xu, Yixin
• Application Number:
  US12/888,864
• Publication Number:
  US 20110014264A1
• Time in Patent Office: Days
• US Class Current: 424/423
• CPC Class Codes: A61L 2300/236 Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
• CPC Class Codes: A61L 2300/252 Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
• CPC Class Codes: A61L 2300/416 Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
• CPC Class Codes: A61L 2300/42 Anti-thrombotic agents, anticoagulants, anti-platelet agents
• CPC Class Codes: A61L 2300/45 Mixtures of two or more drugs, e.g. synergistic mixtures
• CPC Class Codes: A61L 2300/624 Nanocapsules
• CPC Class Codes: A61L 27/50 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
• CPC Class Codes: A61L 27/54 Biologically active materials, e.g. therapeutic substances A61L27/227 takes precedence
• CPC Class Codes: A61L 27/56 Porous materials, e.g. foams or sponges
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61P 35/00 Antineoplastic agents
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• CPC Class Codes: B82Y 30/00 Nanotechnology for materials or surface science, e.g. nanocomposites
• CPC Class Codes: B82Y 5/00 Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Abstract

According to certain aspects of the invention, implantable or insertable medical devices are provided that contain one or more nanoporous regions, which may further comprise interconnected nanopores. Other aspects of the invention are directed to implantable or insertable medical devices that contain one or more nanostructured regions, which are formed by a variety of methods. Still other aspects of the invention are directed to implantable or insertable medical devices having nanotextured surface regions, in which cell-adhesion-promoting biomolecules (e.g., glycosaminoglycans, proteoglycans, cell adhesion peptides, and adhesive proteins) are provided on, within or beneath the nanotextured surface regions.

Claims

1-76. -76. (canceled)

77. An implantable or insertable medical device comprising (a) a ceramic nanoporous region that comprises interconnected nanopores and (b) a biologically active agent disposed within said interconnected nanopores of said nanoporous region, wherein said biologically active agent is a cell-adhesion promoting biomolecule.

78. The implantable or insertable medical device of claim 77, wherein said cell-adhesion promoting biomolecule is selected from glycosaminoglycans, proteoglycans, cell adhesion peptides, and adhesive proteins.

79. The implantable or insertable medical device of claim 77, wherein said nanoporous region is (a) provided in the shape of said medical device or a component of said medical device or (b) provided on a substrate that corresponds to said medical device or a component of said medical device.

80. The implantable or insertable medical device of claim 77, wherein said medical device comprises two or more nanoporous regions.

125. The implantable or insertable medical device of claim 77, wherein said device is a tubular medical device that comprises a nanoporous region comprising said biologically active agent on its inner luminal surface and a nanoporous region comprising a second biologically active agent that differs from said biologically active agent on its outer abluminal surface.

126. The implantable or insertable medical device of claim 125, wherein said device is a vascular stent wherein said second biologically active agent is an antiproliferative agent.

133. The medical device of claim 77, wherein said nanoporous region is a patterned nanoporous region.

134. The medical device of claim 77, wherein said device is an implantable or insertable tubular medical device, and wherein the nanoporous region is provided only on the inner luminal surface of the device.

81. An implantable or insertable medical device comprising (a) a ceramic nanoporous region that comprises interconnected nanopores and (b) a biologically active agent disposed within said interconnected nanopores of said nanoporous region, wherein said biologically active agent is established within said nanoporous region concurrently with the formation of said nanoporous region and at temperatures below the degradation temperature of the biologically active agent and wherein said biologically active agent is a cell-adhesion promoting biomolecule.

82. The implantable or insertable medical device of claim 81, wherein said nanoporous region is formed at temperatures less than 100°

C.

83. The implantable or insertable medical device of claim 81, wherein said biologically active agent is released from said interconnected nanopores upon implantation or insertion of said nanoporous region into a patient.

84. The implantable or insertable medical device of claim 81, wherein said nanoporous region is (a) provided in the shape of said medical device or a component of said medical device or (b) provided on a substrate that corresponds to said medical device or a component of said medical device.

85. The implantable or insertable medical device of claim 81, wherein the lateral dimensions of said interconnected nanopores approach the hydrated radius of the biologically active agent.

86. The implantable or insertable medical device of claim 81, wherein said medical device comprises two or more nanoporous regions.

127. The implantable or insertable medical device of claim 81, wherein said device is a tubular medical device that comprises a nanoporous region comprising said biologically active agent on its inner luminal surface and a nanoporous region comprising a second biologically active agent that differs from said biologically active agent on its outer abluminal surface.

128. The implantable or insertable medical device of claim 127, wherein said device is a vascular stent and wherein said second biologically active agent is an antiproliferative agent.

135. The medical device of claim 81, wherein said nanoporous region is a patterned nanoporous region.

136. The medical device of claim 81, wherein said device is an implantable or insertable tubular medical device.

87. An implantable or insertable medical device comprising a ceramic nanoporous region, said nanoporous region being formed by a method that comprises:

(a) providing a precursor region comprising a first material that is present in nano-domains within said precursor region;

(b) subjecting said precursor region to conditions under which said first material is either reduced in volume or eliminated from said precursor region, thereby forming a ceramic nanoporous region having interconnected nanopores and (c) introducing a biologically active agent into the interconnected nanopores within said nanoporous region, wherein said biologically active agent is a cell-adhesion promoting-biomolecule.

88. The implantable or insertable medical device of claim 87, wherein the lateral dimensions of the nanopores formed within the nanoporous region approach the hydrated radius of the biologically active agent.

89. The implantable or insertable medical device of claim 87, wherein said nanoporous region is (a) provided in the shape of said medical device or a component of said medical device or (b) provided on a substrate that corresponds to said medical device or a component of said medical device.

90. The implantable or insertable medical device of claim 87, wherein said medical device comprises two or more nanoporous regions.

91. The implantable or insertable medical device of claim 87, wherein said precursor region comprises sinterable nanoparticles and evanescent nanoparticles, and wherein said precursor region is heated such that at least a portion of the sinterable nanoparticles are sintered and at least a portion of the evanescent nanoparticles are converted to vapor, thereby forming said nanoporous region.

92. The implantable or insertable medical device of claim 91, wherein said sinterable nanoparticles are metal nanoparticles.

93. The implantable or insertable medical device of claim 91, wherein said sinterable nanoparticles are ceramic nanoparticles.

94. The implantable or insertable medical device of claim 91, wherein said sinterable nanoparticles are bioactive ceramic nanoparticles.

95. The implantable or insertable medical device of claim 91, wherein said sinterable nanoparticles are polymer nanoparticles.

96. The implantable or insertable medical device of claim 91, wherein said evanescent nanoparticles are combustible nanoparticles.

97. The implantable or insertable medical device of claim 91, wherein said evanescent nanoparticles are evaporable nanoparticles.

98. The implantable or insertable medical device of claim 91, wherein said evanescent nanoparticles are sublimable nanoparticles.

99. The implantable or insertable medical device of claim 98, wherein said sublimable nanoparticles comprise a sublimable metal selected from calcium and magnesium.

100. The implantable or insertable medical device of claim 98, wherein said sublimable nanoparticles comprise a sublimable organic compound.

101. The implantable or insertable medical device of claim 91, wherein said evanescent nanoparticles comprise a reducible oxide of a sublimable metal, and wherein said mixture is heated under a reducing atmosphere.

102. The implantable or insertable medical device of claim 91, wherein said nanoporous region comprises a gradient in pore volume.

103. The implantable or insertable medical device of claim 87, wherein said precursor region comprises sinterable nanoparticles and oxide nanoparticles, and wherein said precursor region is heated under reducing conditions such that at least a portion of the sinterable nanoparticles are sintered and at least a portion said reducible oxide nanoparticles are reduced, thereby decreasing the volume of said oxide nanoparticles and establishing said nanoporous region.

129. The implantable or insertable medical device of claim 87, wherein said device is a tubular medical device that comprises a nanoporous region comprising said biologically active agent on its inner luminal surface and a nanoporous region comprising a second biologically active agent that differs from said biologically active agent on its outer abluminal surface.

130. The implantable or insertable medical device of claim 129, wherein said device is a vascular stent and wherein said second biologically active agent is an antiproliferative agent.

137. The medical device of claim 87, wherein said nanoporous region is a patterned nanoporous region.

138. The medical device of claim 87, wherein said device is an implantable or insertable tubular medical device, and wherein the nanoporous region is provided only on the inner luminal surface of the device.

104. An implantable or insertable medical device comprising a ceramic nanostructured region, said nanostructured region provided by a method that comprises one or more of the following processes:

(a) a physical vapor deposition process comprising evaporation of a metal oxide, (b) a physical vapor deposition process comprising sublimation of a metal or ceramic material, (c) a physical vapor deposition process comprising sputtering of a metal or metal oxide, (d) a physical vapor deposition process comprising laser ablation of a metal or ceramic material, (e) simultaneous physical vapor deposition of (i) a metal or a ceramic material and (ii) a biologically active agent, (f) ion deposition of a metal or metal oxide layer, (h) ion implantation into a metal or ceramic surface, (i) X-ray lithography of a metal or ceramic surface, (j) a kinetic metallization process, (k) chemical vapor deposition of a metal or ceramic material, (l) electrodeposition and (m) electroless deposition, wherein said nanostructured region comprises interconnected nanopores and a biologically active agent disposed within the interconnected nanopores of the nanostructured region and wherein said biologically active agent is a cell-adhesion promoting biomolecule.

105. The implantable or insertable medical device of claim 104, wherein said nanostructured region is a nanotextured region.

106. The implantable or insertable medical device of claim 104, wherein said nanostructured region is a nanoporous region.

107. The implantable or insertable medical device of claim 106, wherein said biologically active agent is released from said nanostructured region upon implantation or insertion of said nanoporous region into a patient.

108. The implantable or insertable medical device of claim 106, wherein the lateral dimensions of nanopores in said nanoporous region approach the hydrated radius of the biologically active agent.

109. The implantable or insertable medical device of claim 106, wherein said biologically active agent is established within said nanoporous region concurrently with the formation of said nanoporous region.

110. The implantable or insertable medical device of claim 104, wherein said medical device comprises a plurality of distinct nanoporous regions.

111. The implantable or insertable medical device of claim 104, wherein said nanostructured region comprises a material that is present in nano-domains within said nanostructured region;

and wherein said nanostructured region is subjected to conditions under which said material is either reduced in volume or eliminated from said precursor region, thereby forming a nanoporous region.

112. The implantable or insertable medical device of claim 104, wherein said nanostructured region is provided by a method in which inert gas ions are ionized and accelerated into the surface region during physical vapor deposition.

113. The implantable or insertable medical device of claim 104, wherein said nanostructured region is provided by a method in which at least a portion of the deposited material or a precursor thereof is ionized and accelerated to the surface region during deposition.

114. The implantable or insertable medical device of claim 104, wherein said nanostructured region is provided by a method that comprises an ion implantation process and wherein said implanted ion is an inert ion.

115. The implantable or insertable medical device of claim 104, wherein said nanostructured region is provided by a method that comprises an ion implantation process and wherein said implanted ion is a reactive ion.

116. The implantable or insertable medical device of claim 104, wherein said nanostructured region is provided by a method that comprises an ion implantation process and wherein said implanted ion corresponds to an element or molecule of the surface region into which it is implanted.

117. The implantable or insertable medical device of claim 104, wherein said nanostructured region is provided by a method that comprises a kinetic metallization process and wherein said kinetic metallization process comprises impacting a substrate with two or more metal particle populations, each of different compositions.

118. The implantable or insertable medical device of claim 104, wherein said nanostructured region is provided by a method that comprises a kinetic metallization process and wherein said kinetic metallization process comprises concurrently impacting a substrate with metal particles and with a biologically active agent.

119. The implantable or insertable medical device of claim 104, wherein said nanostructured region is provided by a method that comprises a chemical vapor deposition process and wherein said chemical vapor deposition process is particle-precipitation-aided chemical vapor deposition process.

120. The implantable or insertable medical device of claim 104, wherein said nanostructured region is formed directly on a substrate that corresponds to said medical device or a component of said medical device.

121. The implantable or insertable medical device of claim 104, wherein said nanostructured region is applied after formation to a substrate that corresponds to said medical device or a component of said medical device.

124. The implantable or insertable medical device of claim 104, wherein said nanostructured region is provided by a method that comprises a electrodeposition or electroless deposition process wherein said electrodeposition or electroless deposition process comprises concurrently depositing two or more materials, each of different composition, wherein one or more said materials can be biologically active agents.

131. The implantable or insertable medical device of claim 104, wherein said device is a tubular medical device that comprises a nanoporous region comprising said biologically active agent on its inner luminal surface and a nanoporous region comprising a second biologically active agent that differs from said biologically active agent on its outer abluminal surface.

132. The implantable or insertable medical device of claim 131, wherein said device is a vascular stent and wherein said second biologically active agent is an antiproliferative agent.

139. The medical device of claim 104, wherein said nanostructured region is a patterned nanostructured region.

140. The medical device of claim 104, wherein said device is an implantable or insertable tubular medical device, and wherein the nanostructured region is provided only on the inner luminal surface of the device.

122. An implantable or insertable medical device comprising a nanotextured surface region comprising interconnected nanopores and a cell-adhesion-promoting biomolecule provided within the interconnected nanopores of said nanotextured surface region.

123. The implantable or insertable medical device of claim 122, wherein said cell adhesion-promoting biomolecule is selected from glycosaminoglycans, proteoglycans, cell adhesion peptides, and adhesive proteins.

141. The medical device of claim 122, wherein said nanotextured surface region is a patterned nanotextured surface region.

142. The medical device of claim 122, wherein said device is an implantable or insertable tubular medical device, and wherein the nanotextured surface region is provided only on the inner luminal surface of the device biomolecule.